Section 26B-4-212 - Institutional review board - Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product(1) As used in this section:(a) "Approved study" means a medical research study:(i) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and(ii) that is approved by an IRB.(b) "Board" means the Cannabis Research Review Board created in Section 26B-1-420.(c) "Cannabinoid product" means the same as that term is defined in Section 58-37-3.6.(d) "Cannabis" means the same as that term is defined in Section 58-37-3.6.(e) "Expanded cannabinoid product" means the same as that term is defined in Section 58-37-3.6.(f) "Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.(2) A person conducting an approved study may, for the purposes of the study: (a) process a cannabinoid product or an expanded cannabinoid product;(b) possess a cannabinoid product or an expanded cannabinoid product; and(c) administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.(3) A person conducting an approved study may:(a) import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:(i) the importation complies with federal law; and(ii) the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or(b) obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.(4) A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if: (a) the distribution complies with federal law; and(b) the distribution is for the purposes of, and in accordance with, the approved study.Renumbered from § 26-61-103 and amended by Chapter 307, 2023 General Session ,§ 70, eff. 5/3/2023.Added by Chapter 398, 2017 General Session ,§ 3, eff. 3/25/2017.